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Background
Patients with Ebstein’s anomaly are at risk of tachyar-
rhythmia, congestive heart failure and sudden cardiac
death. There are few data regarding the value of modern
non-invasive diagnostic testing in prediction of out-
comes. Therefore, we aimed to evaluate cardiovascular
magnetic resonance (CMR) and compare it to known
predictors in Ebstein’s anomaly.
Methods
Seventy-nine consecutive adult patients (aged 37±15
years) with unrepaired Ebstein’s anomaly underwent
CMR and were followed prospectively for a mean of 3.5
±2.6years.The major adverse cardiovascular events were
defined as sustained ventricular tachycardia(VT)/heart
failure hospital admission/transplantation or death. Sub-
group analysis of first-onset atrial tachyarrhythmia (AT)
was performed.
Results
Univariate predictors of the major adverse cardiovascu-
lar events (n=6 patients; 3 death, 3 VT) were New York
Heart Association class >2 (Hazard ration (HR 7.66[95%
CI 1.535-38.204],p=0.013), left ventricular (LV) ejection
fraction (HR) 0.43[95%CI 0.245-0.742],p=0.003/5%), LV
stroke volume (HR 0.69[95%CI 0.515-0.923],p=0.013/
5mL) and right ventricular (RV) ejection fraction (HR
0.49[95%CI 0.276-0.856],p=0.012/5%); all remained sig-
nificant even when tested solely for mortality. In all but
one patient VT/death was preceded by AT and AT was
predictive of major adverse cardiovascular events (HR
11.16[95%CI 1.299-95.813],p=0.028), emphasizing its
role as an early marker of long-term adverse events.
Freedom from first-onset AT (n=17 patients, 21.5%)
declined during the follow-up. Univariate predictors for
first-onset AT included RV ejection fraction (HR 0.65
[95%CI 0.463-0.907],p=0.011/5%)], RV/LV end diastolic
volume ratio (HR 1.65[95%CI 1.207-2.258],p=0.002) and
apical tricuspid septal leaflet displacement indexed to
LV length (HR 1.03[95%CI 1.002-1.068],p=0.040); when
used together as a score, risk prediction was further
enhanced (HR 4.84[95%CI 1.615-14.522],p=0.005).
Conclusions
Ventricular functional impairment by CMR was highly
predictive of mortality and VT in a large contemporary
cohort of unrepaired adult patients with Ebstein’s anom-
aly supporting the potential of CMR in risk stratification
and clinical follow up. Furthermore, VT and death were
preceded in almost all patients by presentation of AT
suggesting that AT predicts long term adverse events
early on in the disease progression. Onset of AT was
best predicted by routinely measured CMR parameters
feasible for clinical approach.
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